Portfolio Companies News
December 4, 2019Nordic Nanovector: New preclinical ...
Oslo, Norway, 4 December 2019 Nordic Nanovector ASA (OSE: NANO) announces that new data from preclinical studies investigating the effect of Betalutin® (177Lu-lilotomab satetraxetan) on non-Hodgkin's lymphoma (NHL) cell lines will be presented in a poster at the 61st American Society of H... read more
December 2, 2019Oncopeptides appoints Joseph Horvat...
Stockholm – December 2, 2019 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Joseph Horvat has been appointed as President North America and CEO of Oncopetides Inc. Joseph will serve on the Management Team of Oncopeptides and will start today. The appointment of Joseph H... read more
December 2, 2019Orexo appoints Dennis Urbaniak as E...
Appointment strengthens Orexo’s competencies and resources within digital health Orexo committed to finding innovative solutions to improve treatment of addiction Uppsala, Sweden – December 2, 2019. Orexo AB (publ), the fully integrated specialty pharmaceutical company with the aim... read more
November 27, 2019Orexo acquires exclusive US rights ...
-Deal further strengthens Orexo’s partnership with GAIA -Orexo committed to digital health to address addiction Uppsala, Sweden – November 27, 2019. Orexo AB (publ), the fully integrated specialty pharmaceutical company with the aim of becoming a leader within treatment of addictio... read more
November 19, 2019Interim Report Q3 2019
November 19, 2019 - Regulatory press release Press releases Summary Financial overview July 1 – September 30, 2019 Net sales amounted to SEK 0.0 M (0.0) Loss for the period was SEK 189.8 M (loss: 94.0) Loss per share, before and after dilution, was SEK 3.53 (loss: 2.14) ... read more
October 31, 2019Q3 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 114 portfolio companies.
43 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.